Product Information

CLINDAMYCIN PH 1% GEL is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.1492 per GM under NDC 00168020230. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jan 28, 2000. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN PH 1% GEL

clindamycin phosphate
$0.1492per GM

Strength

10 mg/g

NDC

00168020230

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CLINDAMYCIN PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA064160

FDA Approved

1/28/2000

TE Code

AB1

On Market Since

1/28/2000

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN PH 1% GEL has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 90.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1492 per GM
All-time high$2.0045 (Dec 14, 2016)
All-time low$0.1372 (Jul 22, 2026)
52-week high$0.1599
52-week low$0.1372
Median price$1.1577
Average price$1.0567
Largest weekly change-40.7% (Oct 23, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+1.2%

1M

+4.8%

3M

+7.1%

6M

+7.1%

1Y

-3.3%

3Y

-60.9%

5Y

-83.0%

All

-90.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN PH 1% GEL?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PH 1% GEL, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.1492 per GM (NDC 00168020230), effective Nov 18, 2026.

How has the price of CLINDAMYCIN PH 1% GEL changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN PH 1% GEL has declined 90.9%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PH 1% GEL?

Since Nov 28, 2013, the NADAC for CLINDAMYCIN PH 1% GEL has ranged from a low of $0.1372 (Jul 22, 2026) to a high of $2.0045 (Dec 14, 2016), with a median of $1.1577 per GM.

Are there cheaper alternatives to CLINDAMYCIN PH 1% GEL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PH 1% GEL, is $0.1295 per GM — about 13% below CLINDAMYCIN PH 1% GEL.

Who manufactures CLINDAMYCIN PH 1% GEL?

CLINDAMYCIN PH 1% GEL (NDC 00168020230) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.